Literature DB >> 27973696

Agreement between DSM-IV and DSM-5 criteria for alcohol use disorder among outpatients suffering from depressive and anxiety disorders.

Francesco Bartoli1, Giuseppe Carrà1,2,3, Enrico Biagi2, Cristina Crocamo2, Antonios Dakanalis1, Francesco Di Carlo1, Francesca Parma4, Anna Paola Perin5, Ester Di Giacomo1,2, Luigi Zappa2, Fabio Madeddu4, Fabrizia Colmegna2, Massimo Clerici1,2.   

Abstract

BACKGROUND AND OBJECTIVES: Since significant differences have been reported, we estimated agreement between DSM-5 and DSM-IV criteria for alcohol use disorder (AUD).
METHODS: We assessed 327 outpatients (mean age: 45.2 ± 13.4) with depressive or anxiety disorders.
RESULTS: Absolute differences in prevalence rates between DSM-5 and DSM-IV AUD ranged from -1.1% (subjects with anxiety disorders) to +1.8% (tobacco smokers). The agreement was excellent (k = 0.88), also accounting for specific subgroups (relevant k coefficients >0.80). DISCUSSION AND
CONCLUSIONS: DSM-5 criteria did not inflate AUD rates. SCIENTIFIC SIGNIFICANCE: Our results have epidemiological significance since, unlike previous reports, we found diagnostic stability between new and old AUD criteria in this clinical population. (Am J Addict 2017;26:53-56).
© 2016 American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Year:  2016        PMID: 27973696     DOI: 10.1111/ajad.12482

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  2 in total

1.  Intensity of Daily Drinking and Its Relation to Alcohol Use Disorders.

Authors:  Alvaro Vergés; Jarrod M Ellingson; Stephanie A Schroder; Wendy S Slutske; Kenneth J Sher
Journal:  Alcohol Clin Exp Res       Date:  2018-06-29       Impact factor: 3.455

2.  Sexual orientation and gender identity disparities in substance use disorders during young adulthood in a United States longitudinal cohort.

Authors:  Hee-Jin Jun; Megan Webb-Morgan; Jennifer K Felner; Jennifer P Wisdom; Sean J Haley; S Bryn Austin; Laura M Katuska; Heather L Corliss
Journal:  Drug Alcohol Depend       Date:  2019-10-17       Impact factor: 4.492

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.